<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="147888">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01728987</url>
  </required_header>
  <id_info>
    <org_study_id>TromsøEndo-2012-1</org_study_id>
    <nct_id>NCT01728987</nct_id>
  </id_info>
  <brief_title>The Significance of Vitamin D Storage in Adipose Tissue</brief_title>
  <official_title>The Significance of Vitamin D Storage in Adipose Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tromso</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will examine the role of adipose tissue in vitamin D physiology, particularly its
      role as a depot. the study is randomized double blind and placebo controlled.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      vitamin d versus placebo will be given for 12 months. Biopsies will be taken at baseline and
      every 6 month for 2 years. Blood samples will be collected every 6th month. the study will
      thus give information on storage during vitamin d supplementation as well as use of vitamin
      d fat stores after stopping vitamin D supplementation
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>vitamin D in adipose tissue biopsies</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of decline of 25ohd in serum</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>cholecalciferol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin d (cholecalciferol) will be given as a capsule of 20.000 Iu twice a week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the placebo capsules are looking identical to the vitamin d capsules and contain medium chain triglycerides and arachis oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cholecalciferol</intervention_name>
    <description>as in arm description</description>
    <arm_group_label>cholecalciferol</arm_group_label>
    <other_name>Dekristol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects

        Exclusion Criteria:

          -  hypercalcemia

          -  pregnancy

          -  women without safe contraception
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>rolf jorde, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tromsø, Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rolf Jorde, PhD</last_name>
    <phone>4791740491</phone>
    <email>rolf.jorde@unn.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Tromsø</name>
      <address>
        <city>Tromsø</city>
        <zip>9037</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elisabeth Dahlberg, PhD</last_name>
      <phone>4777644000</phone>
      <email>elisabeth.dahlberg@uit.no</email>
    </contact>
    <investigator>
      <last_name>Rolf Jorde, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 16, 2013</lastchanged_date>
  <firstreceived_date>September 3, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
